Kadınların Farklı Fizyolojik Dönemlerinde Probiyotik Kullanımı
Özet
Bu çalışmada, probiyotiklerin kadın sağlığı üzerindeki etkileri incelenmiştir. Probiyotikler, özellikle Lactobacillus, Bifidobacterium, Streptococcus thermophilus, Escherichia coli ve Saccharomyces boulardii gibi türlerle, kadınların ergenlik, hamilelik, doğum sonrası ve menopoz gibi yaşam evrelerinde vajinal ve bağırsak sağlığını desteklemektedir. Vajinal mikrobiyota dengesinin korunması, enfeksiyon riskinin azaltılması ve genel sağlığın iyileştirilmesi gibi alanlarda probiyotiklerin önemli rol oynadığı, literatürde vurgulanmaktadır. Hamilelik döneminde annenin ve bebeğin sağlığını destekleyen probiyotikler, gestasyonel diyabet riskini azaltmada da etkili olabilir. Menopoz döneminde ise hormonal denge ve kemik sağlığının korunmasında probiyotiklerin faydalı olabileceği öne sürülmektedir..
This study examines the effects of probiotics on women's health, highlighting the beneficial roles of specific strains such as Lactobacillus, Bifidobacterium, Streptococcus thermophilus, Escherichia coli, and Saccharomyces boulardii. Probiotics support vaginal and gut health throughout different stages of a woman's life, including adolescence, pregnancy, postpartum, and menopause. Maintaining a balanced vaginal microbiota is crucial for reducing infection risk and improving overall health. The literature emphasizes the importance of probiotics in these areas, particularly during pregnancy, where they can support both maternal and fetal health and may reduce the risk of gestational diabetes. Additionally, during menopause, probiotics may help maintain hormonal balance and support bone health.
Referanslar
Gupta V, Garg R. Probiotics. Indian journal of medical microbiology. 2009;27(3):202-9.
Biçer D, Gülsüm D, Eminoğlu DÖ. Probiyotikler ve Periodontal Sağlık. Selcuk Dental Journal. 2022;9(2):706-12.
Shafie M, Rad AH, Mohammad-Alizadeh-Charandabi S, Mirghafourvand M. The effect of probiotics on mood and sleep quality in postmenopausal women: a triple-blind randomized controlled trial. Clinical Nutrition ESPEN. 2022;50:15-23.
Mastromarino P, Vitali B, Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013;36(3):229-38.
Harahap IA, Suliburska J. Can probiotics decrease the risk of postmenopausal osteoporosis in women? PharmaNutrition. 2023:100336.
Turroni F, Van Sinderen D, Ventura M. Genomics and ecological overview of the genus Bifidobacterium. International journal of food microbiology. 2011;149(1):37-44.
Andrews R, Lacey A, Roach H, Tomlinson R, Kidd EJ, Bache K. Evaluating the Effects of Probiotics on Menopause-specific Health Outcomes: A Systematic Review & Meta-analysis. 2023.
IŞIDAN H. Probiyotikler. Aquaculture Studies. 2009;2009(1):9-12.
Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Frontiers in microbiology. 2018;9:757.
LV M. Antibiyotik ilişkili ishalin önlenmesi ve Clostridium difficile hastalığının tedavisi için probiyotiklerin meta-analizi. Am J Gastroenterol. 2006;101:812-22.
Gogineni VK, Morrow LE, Malesker M. Probiotics: mechanisms of action and clinical applications. J Prob Health. 2013;1(1):1-11.
Guarner F, Malagelada J-R. Gut flora in health and disease. The lancet. 2003;361(9356):512-9.
Collado MC, Gueimonde M, Salminen S. Probiotics in adhesion of pathogens: mechanisms of action. Bioactive foods in promoting health: Elsevier; 2010. p. 353-70.
Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-32.
Slover CM, Danziger L. Lactobacillus: a review. Clinical Microbiology Newsletter. 2008;30(4):23-7.
Ürkek B, Şengül M, Erkaya T. Saccharomyces boulardii’nin fermente süt ürünlerinde kullanımı. Akademik Gıda. 2014;12(2):108-13.
McFarland LV, Bernasconi P. Saccharomyces boulardii'. A review of an innovative biotherapeutic agent. Microbial ecology in health and disease. 1993;6(4):157-71.
Yu X, Lin C, Yu J, Qi Q, Wang Q. Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy. Microbial biotechnology. 2020;13(3):629-36.
Couvigny B, Thérial C, Gautier C, Renault P, Briandet R, Guédon E. Streptococcus thermophilus biofilm formation: a remnant trait of ancestral commensal life? PloS one. 2015;10(6):e0128099.
Mercenier A. Molecular genetics of Streptococcus thermophilus. FEMS microbiology reviews. 1990;7(1-2):61-77.
Hols P, Hancy F, Fontaine L, Grossiord B, Prozzi D, Leblond-Bourget N, et al. New insights in the molecular biology and physiology of Streptococcus thermophilus revealed by comparative genomics. FEMS microbiology reviews. 2005;29(3):435-63.
Mizgier M, Jarzabek-Bielecka G, Mruczyk K, Kedzia W. The role of diet and probiotics in prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis in adolescent girls and non-pregnant women. Ginekologia Polska. 2020;91(7):412-6.
Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clinical Infectious Diseases. 2001;32(4):e69-e77.
Vaneechoutte M. The human vaginal microbial community. Research in microbiology. 2017;168(9-10):811-25.
Bolton M, Van Der Straten A, Cohen CR. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sexually transmitted diseases. 2008;35(3):214-25.
Boris S, Barbés C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes and infection. 2000;2(5):543-6.
Farage MA, Miller KW, Sobel JD. Dynamics of the vaginal ecosystem—hormonal influences. Infectious Diseases: Research and Treatment. 2010;3:IDRT. S3903.
Hernández-Rodríguez C, Romero-González R, Albani-Campanario M, Figueroa-Damián R, Meraz-Cruz N, Hernández-Guerrero C. Vaginal microbiota of healthy pregnant Mexican women is constituted by four Lactobacillus species and several vaginosis-associated bacteria. Infectious diseases in obstetrics and gynecology. 2011;2011.
Pacha-Herrera D, Vasco G, Cruz-Betancourt C, Galarza JM, Barragán V, Machado A. Vaginal microbiota evaluation and lactobacilli quantification by qPCR in pregnant and non-pregnant women: a pilot study. Frontiers in Cellular and Infection Microbiology. 2020;10:303.
Sobel JD. Vulvovaginal candidosis. The Lancet. 2007;369(9577):1961-71.
Jarząbek-Bielecka G, Pawlaczyk M, Pawlaczyk M, Pawlaczyk M, Pisarska-Krawczyk M, Wojtyła-Buciora P, et al. The problem of inflammation of the female genital system–assessment of girls’ knowledge about prevention and treatment. Medycyna Rodzinna. 2018.
Jagodzinski A, Zielinska E, Laczmanski L, Hirnle L. The early years of life. Are they influenced by our microbiome? Ginekologia polska. 2019;90(4):228-32.
Group PGSE. Statement of the Polish Gynecological Society Expert Group on the use of Macmiror Complex 500. Ginekologia polska. 2012;83(12):956-9.
Jarząbek-Bielecka G, Pawlaczyk M, Pisarska-Krawczyk M, Kędzia W, Mizgier M. Sexually transmitted diseases in adolescents. Current Gynecologic Oncology. 2015;13(1):20.
Skłodowska A, Pawlaczyk M, Jarząbek G. Aspekty kliniczne zapalenia sromu i pochwy u dziewczynek w wieku przedpokwitaniowym (Clinical aspects of vulvovaginitis in pre-pubertal girls). Przegl Derm. 2011;1(98):48-9.
Parsapure R, Rahimiforushani A, Majlessi F, Montazeri A, Sadeghi R, Garmarudi G. Impact of health-promoting educational intervention on lifestyle (nutrition behaviors, physical activity and mental health) related to vaginal health among reproductive-aged women with vaginitis. Iranian Red Crescent Medical Journal. 2016;18(10).
Neggers YH, Nansel TR, Andrews WW, Schwebke JR, Yu K-f, Goldenberg RL, et al. Dietary Intake of Selected Nutrients Affects Bacterial Vaginosis in Women, 3. The Journal of nutrition. 2007;137(9):2128-33.
Al‐Ghazzewi F, Tester R. Biotherapeutic agents and vaginal health. Journal of Applied Microbiology. 2016;121(1):18-27.
Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. Journal of clinical gastroenterology. 2010;44:S16-S8.
Westney OE, Westney LS, Johnson AA, Knight EM, Oyemade UJ, Cole OJ, et al. Nutrition, genital tract infection, hematologic values, and premature rupture of membranes among African American women. The Journal of nutrition. 1994;124:S987-S93.
Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. The Journal of infectious diseases. 2005;192(3):394-8.
Tuddenham S, Ghanem KG, Caulfield LE, Rovner AJ, Robinson C, Shivakoti R, et al. Associations between dietary micronutrient intake and molecular-Bacterial Vaginosis. Reproductive health. 2019;16:1-8.
Buggio L, Somigliana E, Borghi A, Vercellini P. Probiotics and vaginal microecology: fact or fancy? BMC women's health. 2019;19:1-6.
Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nature Reviews Microbiology. 2011;9(1):27-38.
Bastani P, Homayouni A, Ziyadi S, Tabrizian V. Dairy probiotic foods and bacterial vaginosis: a review on mechanism of action. Probiotics, ed EC Rigobelo (Croatia: Intech publishing). 2012:445-56.
Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, et al. Probiotics for vulvovaginal candidiasis in non‐pregnant women. Cochrane Database of Systematic Reviews. 2017(11).
Heitkemper MM, Cain KC, Jarrett ME, Burr RL, Hertig V, Bond EF. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Official journal of the American College of Gastroenterology| ACG. 2003;98(2):420-30.
Moore J, Barlow D, Jewell D, Kennedy S. Do gastrointestinal symptoms vary with the menstrual cycle? BJOG: An International Journal of Obstetrics & Gynaecology. 1998;105(12):1322-5.
Öden Akman A. Primer dismenoresi olan ve olmayan ergenlerde ovulasyon sıklığının belirlenmesi.
Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M, Gynaecology C, Group F. Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea. Cochrane database of systematic reviews. 1996;2015(7).
Judkins TC, Dennis-Wall JC, Sims SM, Colee J, Langkamp-Henken B. Stool frequency and form and gastrointestinal symptoms differ by day of the menstrual cycle in healthy adult women taking oral contraceptives: a prospective observational study. BMC Women's Health. 2020;20:1-9.
Dennis-Wall JC, Culpepper T, Nieves Jr C, Rowe CC, Burns AM, Rusch CT, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. The American Journal of Clinical Nutrition. 2017;105(3):758-67.
Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scandinavian journal of gastroenterology. 2011;46(9):1057-64.
Beke M, Burns AM, Weir S, Solch RJ, Judkins TC, Nieves Jr C, et al. Validation of a novel quality of life questionnaire: the Digestion-associated Quality of Life Questionnaire (DQLQ). Health and Quality of Life Outcomes. 2022;20(1):53.
Majoribanks J, Proctor M, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrheal. Cochrane Database Syst Rev. 2003;4:CD001751.
Judkins TC, Oula M-L, Sims SM, Langkamp-Henken B. The effect of a probiotic on gastrointestinal symptoms due to menstruation in healthy adult women on oral contraceptives: randomized, double-blind, placebo-controlled trial protocol. Trials. 2022;23(1):481.
Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Frontiers in physiology. 2015;6:129628.
France MT, Ma B, Gajer P, Brown S, Humphrys MS, Holm JB, et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:1-15.
Lebeer S, Ahannach S, Wittouck S, Gehrmann T, Eilers T, Oerlemans E, et al. Citizen-science map of the vaginal microbiome. 2022.
Konschuh S, Jayaprakash T, Dolatabadi A, Dayo E, Ramay H, Sycuro L. O02. 3 Reclassification of Atopobium vaginae as three novel Fannyhessea species: implications for understanding their role in bacterial vaginosis. BMJ Publishing Group Ltd; 2021.
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences. 2011;108(supplement_1):4680-7.
van De Wijgert JH, Gill AC, Chikandiwa A, Verwijs MC, Kelly HA, Omar T, et al. Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota. AIDS. 2020;34(1):115-25.
Oerlemans E, Ahannach S, Wittouck S, Dehay E, De Boeck I, Ballet N, et al. Impacts of menstruation, community type, and an oral yeast probiotic on the vaginal microbiome. Msphere. 2022;7(5):e00239-22.
Amabebe E, Anumba DO. The vaginal microenvironment: the physiologic role of lactobacilli. Frontiers in medicine. 2018;5:181.
Mitchell CM, Srinivasan S, Zhan X, Wu MC, Reed SD, Guthrie KA, et al. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause. 2017;24(10):1160-6.
Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. The ISME journal. 2007;1(2):121-33.
Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clinical Infectious Diseases. 2000;30(6):901-7.
van de Wijgert JH, Jespers V. The global health impact of vaginal dysbiosis. Research in microbiology. 2017;168(9-10):859-64.
Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dörffel Y, Scholze J, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. American journal of obstetrics and gynecology. 2008;198(1):97. e1-. e6.
Li C, Wang T, Li Y, Zhang T, Wang Q, He J, et al. Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials. European Journal of Pharmacology. 2019;864:172660.
Moosa Y, Kwon D, De Oliveira T, Wong EB. Determinants of vaginal microbiota composition. Frontiers in cellular and infection microbiology. 2020;10:467.
Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PloS one. 2010;5(4):e10197.
Kaur H, Merchant M, Haque MM, Mande SS. Crosstalk between female gonadal hormones and vaginal microbiota across various phases of women’s gynecological lifecycle. Frontiers in microbiology. 2020;11:503746.
Jarosik GP, Land CB, Duhon P, Chandler Jr R, Mercer T. Acquisition of iron by Gardnerella vaginalis. Infection and immunity. 1998;66(10):5041-7.
Lopes dos Santos Santiago G, Cools P, Verstraelen H, Trog M, Missine G, Aila NE, et al. Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles. PloS one. 2011;6(11):e28180.
Achilles SL, Hillier SL. The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. Aids. 2013;27:S5-S15.
Song SD, Acharya KD, Zhu JE, Deveney CM, Walther-Antonio MR, Tetel MJ, et al. Daily vaginal microbiota fluctuations associated with natural hormonal cycle, contraceptives, diet, and exercise. MSphere. 2020;5(4):10.1128/msphere. 00593-20.
Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Archives of gynecology and obstetrics. 2014;289(3):479-89.
Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy vaginal microbiota and influence of probiotics across the female life span. Frontiers in microbiology. 2022;13:819958.
Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Current Opinion in Clinical Nutrition & Metabolic Care. 2007;10(6):729-34.
Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proceedings of the Nutrition Society. 2010;69(3):434-41.
Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, et al. Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pakistan Journal of Biological Sciences. 2011;14(8):476.
Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. International Journal of Gynecology & Obstetrics. 2009;104:S25-S6.
Lindsay KL, Walsh CA, Brennan L, McAuliffe FM. Probiotics in pregnancy and maternal outcomes: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine. 2013;26(8):772-8.
Aagaard K, Riehle K, Ma J, Segata N, Mistretta T-A, Coarfa C, et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PloS one. 2012;7(6):e36466.
Laker RC, Wlodek ME, Connelly JJ, Yan Z. Epigenetic origins of metabolic disease: the impact of the maternal condition to the offspring epigenome and later health consequences. Food Science and Human Wellness. 2013;2(1):1-11.
Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Science translational medicine. 2014;6(237):237ra65-ra65.
Thomas DW, Greer FR, Nutrition Co, Section on Gastroenterology H, Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217-31.
Gomez A, Barrett H, Callaway L, Nitert M. Probiotics and pregnancy. Current diabetes reports. 2015;15(1):567.
Lende M, Rijhsinghani A. Gestational diabetes: overview with emphasis on medical management. International journal of environmental research and public health. 2020;17(24):9573.
Jamilian M, Amirani E, Asemi Z. The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition. 2019;38(5):2098-105.
Jawad F, Ejaz K. Gestational diabetes mellitus in South Asia: Epidemiology. JPMA The Journal of the Pakistan Medical Association. 2016;66(9 Suppl 1):S5-7.
Ruszała M, Pilszyk A, Niebrzydowska M, Kimber-Trojnar Ż, Trojnar M, Leszczyńska-Gorzelak B. Novel biomolecules in the pathogenesis of gestational diabetes mellitus 2.0. International journal of molecular sciences. 2022;23(8):4364.
Rodriguez Q, Mahdy H. Gestational diabetes. 2019.
Assaf-Balut C, de la Torre NG, Calle-Pascual AL, de la Torre NG, Durán A, Jiménez I, et al. Detection, treatment and prevention programs for gestational diabetes mellitus: The St Carlos experience. Endocrinología, Diabetes y Nutrición (English ed). 2020;67(5):342-50.
Pintaudi B, Di Vieste G, Corrado F, Lucisano G, Giunta L, D'ANNA R, et al. Effects of myo-inositol on glucose variability in women with gestational diabetes. European Review for Medical & Pharmacological Sciences. 2018;22(19).
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470-80.
Dugoua J-J, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. Journal of obstetrics and gynaecology Canada. 2009;31(6):542-52.
Vitacolonna E, Masulli M, Palmisano L, Stuppia L, Franzago M. Inositols, Probiotics, and gestational diabetes: clinical and epigenetic aspects. Nutrients. 2022;14(8):1543.
Babadi M, Khorshidi A, Aghadavood E, Samimi M, Kavossian E, Bahmani F, et al. The effects of probiotic supplementation on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Probiotics and antimicrobial proteins. 2019;11:1227-35.
Taylor BL, Woodfall GE, Sheedy KE, O’Riley ML, Rainbow KA, Bramwell EL, et al. Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2017;9(5):461.
Ilmonen J, Isolauri E, Poussa T, Laitinen K. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clinical nutrition. 2011;30(2):156-64.
Laitinen K, Poussa T, Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. British Journal of Nutrition. 2008;101(11):1679-87.
Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. British journal of nutrition. 2010;103(12):1792-9.
Isolauri E, Rautava S, Collado M, Salminen S. Role of probiotics in reducing the risk of gestational diabetes. Diabetes, Obesity and Metabolism. 2015;17(8):713-9.
Dolatkhah N, Hajifaraji M, Abbasalizadeh F, Aghamohammadzadeh N, Mehrabi Y, Mesgari Abbasi M. Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial. Journal of Health, Population and Nutrition. 2015;33(1):1-8.
Monteiro NE, Queirós LD, Lopes DB, Pedro AO, Macedo GA. Impact of microbiota on the use and effects of isoflavones in the relief of climacteric symptoms in menopausal women–A review. Journal of functional foods. 2018;41:100-11.
Prior JC. Perimenopause and menopause as oestrogen deficiency while ignoring progesterone. Nature Reviews Disease Primers. 2015;1(1):1-.
Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ, et al. Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2015;100(11):4012-20.
Beral V, Banks E, Reeves G, Bull D. Breast cancer and hormone-replacement therapy: the Million Women Study. The Lancet. 2003;362(9392):1330-1.
Vieira AT, Castelo PM, Ribeiro DA, Ferreira CM. Influence of oral and gut microbiota in the health of menopausal women. Frontiers in microbiology. 2017;8:298600.
Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50.
Sivamaruthi BS, Kesika P, Chaiyasut C. Influence of probiotic supplementation on climacteric symptoms in menopausal women-A mini review. International Journal of Applied Pharmaceutics. 2018:43-6.
Yu J, Cao G, Yuan S, Luo C, Yu J, Cai M. Probiotic supplements and bone health in postmenopausal women: a meta-analysis of randomised controlled trials. BMJ open. 2021;11(3):e041393.
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen–gut microbiome axis: Physiological and clinical implications. Maturitas. 2017;103:45-53.
Chen KLA, Liu X, Zhao YC, Hieronymi K, Rossi G, Auvil LS, et al. Long-term administration of conjugated estrogen and bazedoxifene decreased murine fecal β-glucuronidase activity without impacting overall microbiome community. Scientific reports. 2018;8(1):8166.
Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. Journal of translational medicine. 2012;10:1-11.
Peters BA, Santoro N, Kaplan RC, Qi Q. Spotlight on the gut microbiome in menopause: current insights. International Journal of Women's Health. 2022:1059-72.
Indira M, Venkateswarulu T, Abraham Peele K, Nazneen Bobby M, Krupanidhi S. Bioactive molecules of probiotic bacteria and their mechanism of action: a review. 3 Biotech. 2019;9(8):306.
Wu S, Yoon S, Zhang Y-G, Lu R, Xia Y, Wan J, et al. Vitamin D receptor pathway is required for probiotic protection in colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2015;309(5):G341-G9.
Rizzoli R, Biver E. Are probiotics the new calcium and vitamin D for bone health? Current osteoporosis reports. 2020;18:273-84.
Harahap IA, Suliburska J. Probiotics and isoflavones as a promising therapeutic for calcium status and bone health: A narrative review. Foods. 2021;10(11):2685.
Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA. Effects of a multispecies probiotic supplement on bone health in osteopenic postmenopausal women: a randomized, double-blind, controlled trial. Journal of the American College of Nutrition. 2017;36(7):497-506.
Sapra L, Dar HY, Bhardwaj A, Pandey A, Kumari S, Azam Z, et al. Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Scientific reports. 2021;11(1):1807.
Referanslar
Gupta V, Garg R. Probiotics. Indian journal of medical microbiology. 2009;27(3):202-9.
Biçer D, Gülsüm D, Eminoğlu DÖ. Probiyotikler ve Periodontal Sağlık. Selcuk Dental Journal. 2022;9(2):706-12.
Shafie M, Rad AH, Mohammad-Alizadeh-Charandabi S, Mirghafourvand M. The effect of probiotics on mood and sleep quality in postmenopausal women: a triple-blind randomized controlled trial. Clinical Nutrition ESPEN. 2022;50:15-23.
Mastromarino P, Vitali B, Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013;36(3):229-38.
Harahap IA, Suliburska J. Can probiotics decrease the risk of postmenopausal osteoporosis in women? PharmaNutrition. 2023:100336.
Turroni F, Van Sinderen D, Ventura M. Genomics and ecological overview of the genus Bifidobacterium. International journal of food microbiology. 2011;149(1):37-44.
Andrews R, Lacey A, Roach H, Tomlinson R, Kidd EJ, Bache K. Evaluating the Effects of Probiotics on Menopause-specific Health Outcomes: A Systematic Review & Meta-analysis. 2023.
IŞIDAN H. Probiyotikler. Aquaculture Studies. 2009;2009(1):9-12.
Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Frontiers in microbiology. 2018;9:757.
LV M. Antibiyotik ilişkili ishalin önlenmesi ve Clostridium difficile hastalığının tedavisi için probiyotiklerin meta-analizi. Am J Gastroenterol. 2006;101:812-22.
Gogineni VK, Morrow LE, Malesker M. Probiotics: mechanisms of action and clinical applications. J Prob Health. 2013;1(1):1-11.
Guarner F, Malagelada J-R. Gut flora in health and disease. The lancet. 2003;361(9356):512-9.
Collado MC, Gueimonde M, Salminen S. Probiotics in adhesion of pathogens: mechanisms of action. Bioactive foods in promoting health: Elsevier; 2010. p. 353-70.
Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-32.
Slover CM, Danziger L. Lactobacillus: a review. Clinical Microbiology Newsletter. 2008;30(4):23-7.
Ürkek B, Şengül M, Erkaya T. Saccharomyces boulardii’nin fermente süt ürünlerinde kullanımı. Akademik Gıda. 2014;12(2):108-13.
McFarland LV, Bernasconi P. Saccharomyces boulardii'. A review of an innovative biotherapeutic agent. Microbial ecology in health and disease. 1993;6(4):157-71.
Yu X, Lin C, Yu J, Qi Q, Wang Q. Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy. Microbial biotechnology. 2020;13(3):629-36.
Couvigny B, Thérial C, Gautier C, Renault P, Briandet R, Guédon E. Streptococcus thermophilus biofilm formation: a remnant trait of ancestral commensal life? PloS one. 2015;10(6):e0128099.
Mercenier A. Molecular genetics of Streptococcus thermophilus. FEMS microbiology reviews. 1990;7(1-2):61-77.
Hols P, Hancy F, Fontaine L, Grossiord B, Prozzi D, Leblond-Bourget N, et al. New insights in the molecular biology and physiology of Streptococcus thermophilus revealed by comparative genomics. FEMS microbiology reviews. 2005;29(3):435-63.
Mizgier M, Jarzabek-Bielecka G, Mruczyk K, Kedzia W. The role of diet and probiotics in prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis in adolescent girls and non-pregnant women. Ginekologia Polska. 2020;91(7):412-6.
Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clinical Infectious Diseases. 2001;32(4):e69-e77.
Vaneechoutte M. The human vaginal microbial community. Research in microbiology. 2017;168(9-10):811-25.
Bolton M, Van Der Straten A, Cohen CR. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sexually transmitted diseases. 2008;35(3):214-25.
Boris S, Barbés C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes and infection. 2000;2(5):543-6.
Farage MA, Miller KW, Sobel JD. Dynamics of the vaginal ecosystem—hormonal influences. Infectious Diseases: Research and Treatment. 2010;3:IDRT. S3903.
Hernández-Rodríguez C, Romero-González R, Albani-Campanario M, Figueroa-Damián R, Meraz-Cruz N, Hernández-Guerrero C. Vaginal microbiota of healthy pregnant Mexican women is constituted by four Lactobacillus species and several vaginosis-associated bacteria. Infectious diseases in obstetrics and gynecology. 2011;2011.
Pacha-Herrera D, Vasco G, Cruz-Betancourt C, Galarza JM, Barragán V, Machado A. Vaginal microbiota evaluation and lactobacilli quantification by qPCR in pregnant and non-pregnant women: a pilot study. Frontiers in Cellular and Infection Microbiology. 2020;10:303.
Sobel JD. Vulvovaginal candidosis. The Lancet. 2007;369(9577):1961-71.
Jarząbek-Bielecka G, Pawlaczyk M, Pawlaczyk M, Pawlaczyk M, Pisarska-Krawczyk M, Wojtyła-Buciora P, et al. The problem of inflammation of the female genital system–assessment of girls’ knowledge about prevention and treatment. Medycyna Rodzinna. 2018.
Jagodzinski A, Zielinska E, Laczmanski L, Hirnle L. The early years of life. Are they influenced by our microbiome? Ginekologia polska. 2019;90(4):228-32.
Group PGSE. Statement of the Polish Gynecological Society Expert Group on the use of Macmiror Complex 500. Ginekologia polska. 2012;83(12):956-9.
Jarząbek-Bielecka G, Pawlaczyk M, Pisarska-Krawczyk M, Kędzia W, Mizgier M. Sexually transmitted diseases in adolescents. Current Gynecologic Oncology. 2015;13(1):20.
Skłodowska A, Pawlaczyk M, Jarząbek G. Aspekty kliniczne zapalenia sromu i pochwy u dziewczynek w wieku przedpokwitaniowym (Clinical aspects of vulvovaginitis in pre-pubertal girls). Przegl Derm. 2011;1(98):48-9.
Parsapure R, Rahimiforushani A, Majlessi F, Montazeri A, Sadeghi R, Garmarudi G. Impact of health-promoting educational intervention on lifestyle (nutrition behaviors, physical activity and mental health) related to vaginal health among reproductive-aged women with vaginitis. Iranian Red Crescent Medical Journal. 2016;18(10).
Neggers YH, Nansel TR, Andrews WW, Schwebke JR, Yu K-f, Goldenberg RL, et al. Dietary Intake of Selected Nutrients Affects Bacterial Vaginosis in Women, 3. The Journal of nutrition. 2007;137(9):2128-33.
Al‐Ghazzewi F, Tester R. Biotherapeutic agents and vaginal health. Journal of Applied Microbiology. 2016;121(1):18-27.
Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. Journal of clinical gastroenterology. 2010;44:S16-S8.
Westney OE, Westney LS, Johnson AA, Knight EM, Oyemade UJ, Cole OJ, et al. Nutrition, genital tract infection, hematologic values, and premature rupture of membranes among African American women. The Journal of nutrition. 1994;124:S987-S93.
Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. The Journal of infectious diseases. 2005;192(3):394-8.
Tuddenham S, Ghanem KG, Caulfield LE, Rovner AJ, Robinson C, Shivakoti R, et al. Associations between dietary micronutrient intake and molecular-Bacterial Vaginosis. Reproductive health. 2019;16:1-8.
Buggio L, Somigliana E, Borghi A, Vercellini P. Probiotics and vaginal microecology: fact or fancy? BMC women's health. 2019;19:1-6.
Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nature Reviews Microbiology. 2011;9(1):27-38.
Bastani P, Homayouni A, Ziyadi S, Tabrizian V. Dairy probiotic foods and bacterial vaginosis: a review on mechanism of action. Probiotics, ed EC Rigobelo (Croatia: Intech publishing). 2012:445-56.
Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, et al. Probiotics for vulvovaginal candidiasis in non‐pregnant women. Cochrane Database of Systematic Reviews. 2017(11).
Heitkemper MM, Cain KC, Jarrett ME, Burr RL, Hertig V, Bond EF. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Official journal of the American College of Gastroenterology| ACG. 2003;98(2):420-30.
Moore J, Barlow D, Jewell D, Kennedy S. Do gastrointestinal symptoms vary with the menstrual cycle? BJOG: An International Journal of Obstetrics & Gynaecology. 1998;105(12):1322-5.
Öden Akman A. Primer dismenoresi olan ve olmayan ergenlerde ovulasyon sıklığının belirlenmesi.
Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M, Gynaecology C, Group F. Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea. Cochrane database of systematic reviews. 1996;2015(7).
Judkins TC, Dennis-Wall JC, Sims SM, Colee J, Langkamp-Henken B. Stool frequency and form and gastrointestinal symptoms differ by day of the menstrual cycle in healthy adult women taking oral contraceptives: a prospective observational study. BMC Women's Health. 2020;20:1-9.
Dennis-Wall JC, Culpepper T, Nieves Jr C, Rowe CC, Burns AM, Rusch CT, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. The American Journal of Clinical Nutrition. 2017;105(3):758-67.
Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scandinavian journal of gastroenterology. 2011;46(9):1057-64.
Beke M, Burns AM, Weir S, Solch RJ, Judkins TC, Nieves Jr C, et al. Validation of a novel quality of life questionnaire: the Digestion-associated Quality of Life Questionnaire (DQLQ). Health and Quality of Life Outcomes. 2022;20(1):53.
Majoribanks J, Proctor M, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrheal. Cochrane Database Syst Rev. 2003;4:CD001751.
Judkins TC, Oula M-L, Sims SM, Langkamp-Henken B. The effect of a probiotic on gastrointestinal symptoms due to menstruation in healthy adult women on oral contraceptives: randomized, double-blind, placebo-controlled trial protocol. Trials. 2022;23(1):481.
Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Frontiers in physiology. 2015;6:129628.
France MT, Ma B, Gajer P, Brown S, Humphrys MS, Holm JB, et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:1-15.
Lebeer S, Ahannach S, Wittouck S, Gehrmann T, Eilers T, Oerlemans E, et al. Citizen-science map of the vaginal microbiome. 2022.
Konschuh S, Jayaprakash T, Dolatabadi A, Dayo E, Ramay H, Sycuro L. O02. 3 Reclassification of Atopobium vaginae as three novel Fannyhessea species: implications for understanding their role in bacterial vaginosis. BMJ Publishing Group Ltd; 2021.
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences. 2011;108(supplement_1):4680-7.
van De Wijgert JH, Gill AC, Chikandiwa A, Verwijs MC, Kelly HA, Omar T, et al. Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota. AIDS. 2020;34(1):115-25.
Oerlemans E, Ahannach S, Wittouck S, Dehay E, De Boeck I, Ballet N, et al. Impacts of menstruation, community type, and an oral yeast probiotic on the vaginal microbiome. Msphere. 2022;7(5):e00239-22.
Amabebe E, Anumba DO. The vaginal microenvironment: the physiologic role of lactobacilli. Frontiers in medicine. 2018;5:181.
Mitchell CM, Srinivasan S, Zhan X, Wu MC, Reed SD, Guthrie KA, et al. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause. 2017;24(10):1160-6.
Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. The ISME journal. 2007;1(2):121-33.
Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clinical Infectious Diseases. 2000;30(6):901-7.
van de Wijgert JH, Jespers V. The global health impact of vaginal dysbiosis. Research in microbiology. 2017;168(9-10):859-64.
Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dörffel Y, Scholze J, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. American journal of obstetrics and gynecology. 2008;198(1):97. e1-. e6.
Li C, Wang T, Li Y, Zhang T, Wang Q, He J, et al. Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials. European Journal of Pharmacology. 2019;864:172660.
Moosa Y, Kwon D, De Oliveira T, Wong EB. Determinants of vaginal microbiota composition. Frontiers in cellular and infection microbiology. 2020;10:467.
Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PloS one. 2010;5(4):e10197.
Kaur H, Merchant M, Haque MM, Mande SS. Crosstalk between female gonadal hormones and vaginal microbiota across various phases of women’s gynecological lifecycle. Frontiers in microbiology. 2020;11:503746.
Jarosik GP, Land CB, Duhon P, Chandler Jr R, Mercer T. Acquisition of iron by Gardnerella vaginalis. Infection and immunity. 1998;66(10):5041-7.
Lopes dos Santos Santiago G, Cools P, Verstraelen H, Trog M, Missine G, Aila NE, et al. Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles. PloS one. 2011;6(11):e28180.
Achilles SL, Hillier SL. The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. Aids. 2013;27:S5-S15.
Song SD, Acharya KD, Zhu JE, Deveney CM, Walther-Antonio MR, Tetel MJ, et al. Daily vaginal microbiota fluctuations associated with natural hormonal cycle, contraceptives, diet, and exercise. MSphere. 2020;5(4):10.1128/msphere. 00593-20.
Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Archives of gynecology and obstetrics. 2014;289(3):479-89.
Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy vaginal microbiota and influence of probiotics across the female life span. Frontiers in microbiology. 2022;13:819958.
Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Current Opinion in Clinical Nutrition & Metabolic Care. 2007;10(6):729-34.
Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proceedings of the Nutrition Society. 2010;69(3):434-41.
Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, et al. Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pakistan Journal of Biological Sciences. 2011;14(8):476.
Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. International Journal of Gynecology & Obstetrics. 2009;104:S25-S6.
Lindsay KL, Walsh CA, Brennan L, McAuliffe FM. Probiotics in pregnancy and maternal outcomes: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine. 2013;26(8):772-8.
Aagaard K, Riehle K, Ma J, Segata N, Mistretta T-A, Coarfa C, et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PloS one. 2012;7(6):e36466.
Laker RC, Wlodek ME, Connelly JJ, Yan Z. Epigenetic origins of metabolic disease: the impact of the maternal condition to the offspring epigenome and later health consequences. Food Science and Human Wellness. 2013;2(1):1-11.
Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Science translational medicine. 2014;6(237):237ra65-ra65.
Thomas DW, Greer FR, Nutrition Co, Section on Gastroenterology H, Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217-31.
Gomez A, Barrett H, Callaway L, Nitert M. Probiotics and pregnancy. Current diabetes reports. 2015;15(1):567.
Lende M, Rijhsinghani A. Gestational diabetes: overview with emphasis on medical management. International journal of environmental research and public health. 2020;17(24):9573.
Jamilian M, Amirani E, Asemi Z. The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition. 2019;38(5):2098-105.
Jawad F, Ejaz K. Gestational diabetes mellitus in South Asia: Epidemiology. JPMA The Journal of the Pakistan Medical Association. 2016;66(9 Suppl 1):S5-7.
Ruszała M, Pilszyk A, Niebrzydowska M, Kimber-Trojnar Ż, Trojnar M, Leszczyńska-Gorzelak B. Novel biomolecules in the pathogenesis of gestational diabetes mellitus 2.0. International journal of molecular sciences. 2022;23(8):4364.
Rodriguez Q, Mahdy H. Gestational diabetes. 2019.
Assaf-Balut C, de la Torre NG, Calle-Pascual AL, de la Torre NG, Durán A, Jiménez I, et al. Detection, treatment and prevention programs for gestational diabetes mellitus: The St Carlos experience. Endocrinología, Diabetes y Nutrición (English ed). 2020;67(5):342-50.
Pintaudi B, Di Vieste G, Corrado F, Lucisano G, Giunta L, D'ANNA R, et al. Effects of myo-inositol on glucose variability in women with gestational diabetes. European Review for Medical & Pharmacological Sciences. 2018;22(19).
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470-80.
Dugoua J-J, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. Journal of obstetrics and gynaecology Canada. 2009;31(6):542-52.
Vitacolonna E, Masulli M, Palmisano L, Stuppia L, Franzago M. Inositols, Probiotics, and gestational diabetes: clinical and epigenetic aspects. Nutrients. 2022;14(8):1543.
Babadi M, Khorshidi A, Aghadavood E, Samimi M, Kavossian E, Bahmani F, et al. The effects of probiotic supplementation on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Probiotics and antimicrobial proteins. 2019;11:1227-35.
Taylor BL, Woodfall GE, Sheedy KE, O’Riley ML, Rainbow KA, Bramwell EL, et al. Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2017;9(5):461.
Ilmonen J, Isolauri E, Poussa T, Laitinen K. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clinical nutrition. 2011;30(2):156-64.
Laitinen K, Poussa T, Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. British Journal of Nutrition. 2008;101(11):1679-87.
Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. British journal of nutrition. 2010;103(12):1792-9.
Isolauri E, Rautava S, Collado M, Salminen S. Role of probiotics in reducing the risk of gestational diabetes. Diabetes, Obesity and Metabolism. 2015;17(8):713-9.
Dolatkhah N, Hajifaraji M, Abbasalizadeh F, Aghamohammadzadeh N, Mehrabi Y, Mesgari Abbasi M. Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial. Journal of Health, Population and Nutrition. 2015;33(1):1-8.
Monteiro NE, Queirós LD, Lopes DB, Pedro AO, Macedo GA. Impact of microbiota on the use and effects of isoflavones in the relief of climacteric symptoms in menopausal women–A review. Journal of functional foods. 2018;41:100-11.
Prior JC. Perimenopause and menopause as oestrogen deficiency while ignoring progesterone. Nature Reviews Disease Primers. 2015;1(1):1-.
Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ, et al. Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2015;100(11):4012-20.
Beral V, Banks E, Reeves G, Bull D. Breast cancer and hormone-replacement therapy: the Million Women Study. The Lancet. 2003;362(9392):1330-1.
Vieira AT, Castelo PM, Ribeiro DA, Ferreira CM. Influence of oral and gut microbiota in the health of menopausal women. Frontiers in microbiology. 2017;8:298600.
Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50.
Sivamaruthi BS, Kesika P, Chaiyasut C. Influence of probiotic supplementation on climacteric symptoms in menopausal women-A mini review. International Journal of Applied Pharmaceutics. 2018:43-6.
Yu J, Cao G, Yuan S, Luo C, Yu J, Cai M. Probiotic supplements and bone health in postmenopausal women: a meta-analysis of randomised controlled trials. BMJ open. 2021;11(3):e041393.
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen–gut microbiome axis: Physiological and clinical implications. Maturitas. 2017;103:45-53.
Chen KLA, Liu X, Zhao YC, Hieronymi K, Rossi G, Auvil LS, et al. Long-term administration of conjugated estrogen and bazedoxifene decreased murine fecal β-glucuronidase activity without impacting overall microbiome community. Scientific reports. 2018;8(1):8166.
Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. Journal of translational medicine. 2012;10:1-11.
Peters BA, Santoro N, Kaplan RC, Qi Q. Spotlight on the gut microbiome in menopause: current insights. International Journal of Women's Health. 2022:1059-72.
Indira M, Venkateswarulu T, Abraham Peele K, Nazneen Bobby M, Krupanidhi S. Bioactive molecules of probiotic bacteria and their mechanism of action: a review. 3 Biotech. 2019;9(8):306.
Wu S, Yoon S, Zhang Y-G, Lu R, Xia Y, Wan J, et al. Vitamin D receptor pathway is required for probiotic protection in colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2015;309(5):G341-G9.
Rizzoli R, Biver E. Are probiotics the new calcium and vitamin D for bone health? Current osteoporosis reports. 2020;18:273-84.
Harahap IA, Suliburska J. Probiotics and isoflavones as a promising therapeutic for calcium status and bone health: A narrative review. Foods. 2021;10(11):2685.
Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA. Effects of a multispecies probiotic supplement on bone health in osteopenic postmenopausal women: a randomized, double-blind, controlled trial. Journal of the American College of Nutrition. 2017;36(7):497-506.
Sapra L, Dar HY, Bhardwaj A, Pandey A, Kumari S, Azam Z, et al. Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Scientific reports. 2021;11(1):1807.
